Cancer care, money, and the value of life: whose justice? Which rationality?
about
Drug waste minimisation and cost-containment in Medical Oncology: two-year results of a feasibility study.A North-European perspective challenges the UK NICE system for resource allocation.Costs, evidence, and value in the Medicare program: the challenges of technology innovation in breast cancer prevention and control."Just caring": can we afford the ethical and economic costs of circumventing cancer drug resistance?A model to estimate human resource needs for the treatment of outpatients with cancer.Ethical challenges: caring for the underinsured, geographically disadvantaged patient."Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer.Quantitative medical cost-effectiveness analysis of molecular-targeting cancer drugs in JapanIn a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gains in survival.The moral psychology of rationing among physicians: the role of harm and fairness intuitions in physician objections to cost-effectiveness and cost-containment.Private Practice Administrative Costs Influenced by Insurance Payer Mix.Can help for patients be too expensive? Ethical considerations and end-stage lung disease.Context and scale: Distinctions for improving debates about physician "rationing".A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.Valuing end-of-life care in the United States: the case of new cancer drugs.
P2860
Q33326482-7E04BEC5-B034-465C-86CD-F164402A4047Q33626909-1CCF5E83-95B4-41DA-AA88-DD8D64FD937AQ33809046-C5BFC98A-1256-4612-9643-20365AE95835Q34608734-F99E6590-8261-4AEA-B10A-77E39B203861Q35695777-AEE324F5-5641-4C53-8F05-FEF6F758A1EBQ36095214-16EA985F-D436-41BD-9804-02FDC623D2EFQ36565670-E5D47FEB-F3EB-45BF-B1EF-923B34C9AD3CQ36921715-A4C12C88-0FE2-4885-BEC5-4720A69C3907Q37289756-B9208407-7933-4970-A484-D84595C8336EQ37357148-85EDF4D7-1B69-4735-B750-B8BA40FE47A2Q37416800-05B33906-0207-4C46-BDAB-F6BB5A732C9AQ37945444-57C71FA4-B7A9-412C-B413-8758BC4E9110Q42351629-6D061178-8025-4EA8-AC8F-F397F01B3540Q46031100-67D959B8-D9AE-4842-9364-411527799C87Q47563275-048CDAF3-E131-41F7-A97A-9E6F080A6759
P2860
Cancer care, money, and the value of life: whose justice? Which rationality?
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cancer care, money, and the value of life: whose justice? Which rationality?
@ast
Cancer care, money, and the value of life: whose justice? Which rationality?
@en
Cancer care, money, and the value of life: whose justice? Which rationality?
@nl
type
label
Cancer care, money, and the value of life: whose justice? Which rationality?
@ast
Cancer care, money, and the value of life: whose justice? Which rationality?
@en
Cancer care, money, and the value of life: whose justice? Which rationality?
@nl
prefLabel
Cancer care, money, and the value of life: whose justice? Which rationality?
@ast
Cancer care, money, and the value of life: whose justice? Which rationality?
@en
Cancer care, money, and the value of life: whose justice? Which rationality?
@nl
P356
P1476
Cancer care, money, and the value of life: whose justice? Which rationality?
@en
P2093
Daniel P Sulmasy
P304
P356
10.1200/JCO.2006.08.0481
P407
P577
2007-01-01T00:00:00Z